Literature DB >> 23541691

Quantitative determinations of anti-Kaposi sarcoma-associated herpesvirus antibody levels in men who have sex with men.

Emile Gogineni1, Vickie Marshall, Wendell Miley, Ahmad Bayat, Denise Whitby, Joseph A Kovacs, Peter D Burbelo.   

Abstract

Infection with Kaposi sarcoma-associated herpesvirus (KSHV; also called human herpesvirus-8) is common among men who have sex with men (MSM). Here, quantitative anti-KSHV antibody levels were measured using luciferase immunoprecipitation systems (LIPS) in an MSM cohort with and without HIV from the NIH Clinical Center. Antibodies were detected using a mixture of 4 KSHV antigens in the MSM cohort and in Kaposi sarcoma (KS) patients. Along with HIV status, these results were compared with K8.1 and ORF73 ELISA, PCR virus detection, and additional LIPS testing. LIPS revealed that 25% (76/307) of the MSM cohort were KSHV seropositive, including 59 HIV+ and 17 HIV- subjects. The anti-KSHV antibody levels detected by LIPS were not statistically different between the KSHV+/HIV+ and KSHV+/HIV- subgroups but were lower than the KS patients (P < 0.0001). ELISA analysis of the MSM cohort detected a 35.5% frequency of KSHV infection and showed agreement with 81% of the samples evaluated by LIPS. Further LIPS testing with v-cyclin, a second ORF73 fragment and ORF38 reconciled some of the differences observed between LIPS and the ELISA immunoassays, and the revised LIPS seroprevalence in the MSM cohort was increased to 31%. Additional quantitative antibody analysis demonstrated statistically lower KSHV antibody levels in MSM compared to KS patients, but no difference was found between KSHV infected with and without HIV coinfection. These findings also suggest that antibodies against v-cyclin and ORF38 are useful for identifying patients with asymptomatic KSHV infection. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23541691      PMCID: PMC3634905          DOI: 10.1016/j.diagmicrobio.2013.02.026

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  22 in total

1.  Risk factors for human herpesvirus 8 seropositivity in the AIDS Cancer Cohort Study.

Authors:  Sam M Mbulaiteye; Jonnae O Atkinson; Denise Whitby; David A Wohl; Joel E Gallant; Scott Royal; James J Goedert; Charles S Rabkin
Journal:  J Clin Virol       Date:  2006-01-18       Impact factor: 3.168

2.  HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study.

Authors:  C Casper; D Carrell; K G Miller; F D Judson; A S Meier; J S Pauk; R A Morrow; L Corey; A Wald; C Celum
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

3.  Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions.

Authors:  Denise Whitby; Vickie A Marshall; Rachel K Bagni; Wendell J Miley; Thomas G McCloud; Rebecca Hines-Boykin; James J Goedert; Betty A Conde; Kunio Nagashima; Judy Mikovits; Dirk P Dittmer; David J Newman
Journal:  Int J Cancer       Date:  2007-01-15       Impact factor: 7.396

4.  Use of a multiantigen detection algorithm for diagnosis of Kaposi's sarcoma-associated herpesvirus infection.

Authors:  A Scott Laney; Jonathan S Peters; Susan M Manzi; Lawrence A Kingsley; Yuan Chang; Patrick S Moore
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

5.  Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men.

Authors:  Corey Casper; Anna Wald; John Pauk; Stephen R Tabet; Lawrence Corey; Connie L Celum
Journal:  J Infect Dis       Date:  2002-03-11       Impact factor: 5.226

6.  Mucosal shedding of human herpesvirus 8 in men.

Authors:  J Pauk; M L Huang; S J Brodie; A Wald; D M Koelle; T Schacker; C Celum; S Selke; L Corey
Journal:  N Engl J Med       Date:  2000-11-09       Impact factor: 91.245

7.  Sexual transmission and the natural history of human herpesvirus 8 infection.

Authors:  J N Martin; D E Ganem; D H Osmond; K A Page-Shafer; D Macrae; D H Kedes
Journal:  N Engl J Med       Date:  1998-04-02       Impact factor: 91.245

8.  Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission.

Authors:  Eric A Engels; Jonnae O Atkinson; Barry I Graubard; Geraldine M McQuillan; Christine Gamache; Georgina Mbisa; Silvia Cohn; Denise Whitby; James J Goedert
Journal:  J Infect Dis       Date:  2007-06-04       Impact factor: 5.226

9.  Antibody reactivity to latent and lytic antigens to human herpesvirus-8 in longitudinally followed homosexual men.

Authors:  Robert J Biggar; Eric A Engels; Denise Whitby; Dean H Kedes; James J Goedert
Journal:  J Infect Dis       Date:  2002-12-13       Impact factor: 5.226

10.  Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray.

Authors:  Dasheng Zheng; Jun Wan; Yong Gu Cho; Leyao Wang; Chuang-Jiun Chiou; Shweta Pai; Crystal Woodard; Jian Zhu; Gangling Liao; Otoniel Martinez-Maza; Jiang Qian; Heng Zhu; Gary S Hayward; Richard F Ambinder; S Diane Hayward
Journal:  J Infect Dis       Date:  2011-10-11       Impact factor: 5.226

View more
  1 in total

Review 1.  Dermatologic care for lesbian, gay, bisexual, and transgender persons: Epidemiology, screening, and disease prevention.

Authors:  Howa Yeung; Kevin M Luk; Suephy C Chen; Brian A Ginsberg; Kenneth A Katz
Journal:  J Am Acad Dermatol       Date:  2019-03       Impact factor: 11.527

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.